Recent Publications on Oncolytic Virotherapy: |  |
Fighting fire with fire: effects of oncolytic virotherapy on underlying viral hepatitis in hepatocellular carcinoma.
Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular...
Direct Link | 30th August, 2008
| University of California, San Diego, La Jolla, California 92093, USA.
|
Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor.
Angiogenesis plays a key role in the development of a wide variety of...
Direct Link | 22nd August, 2008
| Institute of Biochemistry and Cell Biology, Shanghai Institutes for
|
Development of targeted oncolytic virotherapeutics through translational research.
BACKGROUND: Oncolytic virotherapeutics is a promising platform for cancer...
Direct Link | 13th August, 2008
| Jennerex Biotherapeutics, One Market Street, Spear Tower, Suite 2260, San
|
Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
RNA interference (RNAi) has been proved to be a powerful tool for gene...
Direct Link | 12th August, 2008
| [1] 1Laboratory of Urology, Affiliated Hospital of Xuzhou Medical College,
|
Construction of a fully retargeted herpes simplex virus 1 capable to enter cells solely via the human epidermal growth factor receptor 2 (HER2).
A novel frontier in the treatment of tumors difficult to treat is...
Direct Link | 8th August, 2008
| Department of Experimental Pathology, Section on Microbiology and
|
| Virus combinations and chemotherapy for the treatment of human cancers.
| 7th August, 2008
| University of California, San Diego, Department of Hematology and
|
| Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.
| 7th August, 2008
| Yonsei University College of Medicine, Brain Korea 21 Project for Medical
|
Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus.
Liver tropism of systemically delivered adenoviruses (Ad) represents a...
Direct Link | 7th August, 2008
| Division of Infectious Diseases, Department of Internal Medicine, Mayo
|
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
To improve the efficacy and selectivity of virotherapy for malignant...
Direct Link | 7th August, 2008
| The Brain Tumor Center, The University of Chicago, Chicago, Illinois, USA.
|
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
It has been proposed that human tumors contain stem cells that have a...
Direct Link | 7th August, 2008
| Cancer Gene Therapy Group, Molecular Cancer Biology Program and
|
Immunotherapeutic potential of oncolytic virotherapy.
Cells with stem cell-like attributes, such as self-renewal and...
Direct Link | 30th July, 2008
|
|
Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
We evaluated the therapeutic potential of the replication competent vector...
Direct Link | 25th July, 2008
| A. I. Virtanen Institute, Department of Biotechnology and Molecular
|
| Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells.
| 19th July, 2008
| Department of Experimental Virology, Institute of Hematology and Blood
|
The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma.
JX-594 is a targeted oncolytic poxvirus that is designed to eradicate...
Direct Link | 17th July, 2008
| JENNEREX Biotherapeutics, San Francisco, California 94105, USA.
|
Cancer, stem cells, and oncolytic viruses.
Cells with stem cell-like attributes, such as self-renewal and...
Direct Link | 9th July, 2008
| Cancer Gene Therapy Group, Molecular Cancer Biology Program, University of
|
